269 related articles for article (PubMed ID: 34751242)
1. New Peptide-Drug Conjugates for Precise Targeting of SORT1-Mediated Vasculogenic Mimicry in the Tumor Microenvironment of TNBC-Derived MDA-MB-231 Breast and Ovarian ES-2 Clear Cell Carcinoma Cells.
Charfi C; Demeule M; Currie JC; Larocque A; Zgheib A; Danalache BA; Ouanouki A; Béliveau R; Marsolais C; Annabi B
Front Oncol; 2021; 11():760787. PubMed ID: 34751242
[TBL] [Abstract][Full Text] [Related]
2. Antibody-Drug Conjugate αEGFR-E-P125A Reduces Triple-negative Breast Cancer Vasculogenic Mimicry, Motility, and Metastasis through Inhibition of EGFR, Integrin, and FAK/STAT3 Signaling.
Sankar AP; Cho HM; Shin SU; Sneh T; Ramakrishnan S; Elledge C; Zhang Y; Das R; Gil-Henn H; Rosenblatt JD
Cancer Res Commun; 2024 Mar; 4(3):738-756. PubMed ID: 38315147
[TBL] [Abstract][Full Text] [Related]
3. The Inhibition of the FGFR/PI3K/Akt Axis by AZD4547 Disrupts the Proangiogenic Microenvironment and Vasculogenic Mimicry Arising from the Interplay between Endothelial and Triple-Negative Breast Cancer Cells.
Morales-Guadarrama G; Méndez-Pérez EA; García-Quiroz J; Avila E; Ibarra-Sánchez MJ; Esparza-López J; García-Becerra R; Larrea F; Díaz L
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762073
[TBL] [Abstract][Full Text] [Related]
4. LIFU/MMP-2 dual-responsive release of repurposed drug disulfiram from nanodroplets for inhibiting vasculogenic mimicry and lung metastasis in triple-negative breast cancer.
Liu Y; Tang R; Cao Y; Wu N; Qin Q; Chen Y; Wei X; Ren J; Sun Y; Zhou H; Zhou Y; Li P
J Nanobiotechnology; 2024 Apr; 22(1):209. PubMed ID: 38664830
[TBL] [Abstract][Full Text] [Related]
5. Vasculogenic mimicry regulates immune infiltration and mutational status of the tumor microenvironment in breast cancer to influence tumor prognosis.
Zheng S; Guo G; Yang Z; Lu Y; Lu K; Fu W; Huang Q
Environ Toxicol; 2024 May; 39(5):2948-2960. PubMed ID: 38308456
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the Prognostic Significance of Vasculogenic Mimicry and Its Inhibition by Sorafenib in Canine Mammary Gland Tumors.
Prado MCM; Macedo SAL; Guiraldelli GG; de Faria Lainetti P; Leis-Filho AF; Kobayashi PE; Laufer-Amorim R; Fonseca-Alves CE
Front Oncol; 2019; 9():1445. PubMed ID: 31921690
[TBL] [Abstract][Full Text] [Related]
7. DPY19L3 promotes vasculogenic mimicry by its
Baydoun H; Kato Y; Kamo H; Hüsch A; Mizuta H; Kawahara R; Simizu S
Oncol Res; 2024; 32(4):607-614. PubMed ID: 38560568
[No Abstract] [Full Text] [Related]
8. Pan-cancer dissection of vasculogenic mimicry characteristic to provide potential therapeutic targets.
Tang H; Chen L; Liu X; Zeng S; Tan H; Chen G
Front Pharmacol; 2024; 15():1346719. PubMed ID: 38694917
[TBL] [Abstract][Full Text] [Related]
9. Functional roles of microRNAs in vasculogenic mimicry and resistance to therapy in human cancers: an update.
García-Hernández AP; Sánchez-Sánchez G; Carlos-Reyes A; López-Camarillo C
Expert Rev Clin Immunol; 2024 May; ():1-14. PubMed ID: 38712535
[TBL] [Abstract][Full Text] [Related]
10. Novel Iodine nanoparticles target vascular mimicry in intracerebral triple negative human MDA-MB-231 breast tumors.
Ridwan SM; Hainfeld JF; Ross V; Stanishevskiy Y; Smilowitz HM
Sci Rep; 2021 Jan; 11(1):1203. PubMed ID: 33441981
[TBL] [Abstract][Full Text] [Related]
11. Comparative Analysis of Vascular Mimicry in Head and Neck Squamous Cell Carcinoma: In Vitro and In Vivo Approaches.
Hujanen R; Almahmoudi R; Salo T; Salem A
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638234
[TBL] [Abstract][Full Text] [Related]
12. Intracellular pH dynamics respond to microenvironment stiffening and mediate vasculogenic mimicry through β-catenin.
Lund LM; Marchi AN; Alderfer L; Hall E; Hammer J; Trull KJ; Hanjaya-Putra D; White KA
bioRxiv; 2024 Jun; ():. PubMed ID: 38895391
[TBL] [Abstract][Full Text] [Related]
13. Repurposing Drugs to Modulate Sortilin: Structure-Guided Strategies Against Atherogenesis, Coronary Artery Disease, and Neurological Disorders.
Almoyad MAA; Wahab S; Mohanto S; Khan NJ
ACS Omega; 2024 Apr; 9(16):18438-18448. PubMed ID: 38680294
[TBL] [Abstract][Full Text] [Related]
14. Network Proteins of Human Sortilin1, Its Expression and Targetability Using Lycopene.
Kumar AHS
Life (Basel); 2024 Jan; 14(1):. PubMed ID: 38255751
[TBL] [Abstract][Full Text] [Related]
15. The Peptide-Drug Conjugate TH1902: A New Sortilin Receptor-Mediated Cancer Therapeutic against Ovarian and Endometrial Cancers.
Currie JC; Demeule M; Charfi C; Zgheib A; Larocque A; Danalache BA; Ouanouki A; Béliveau R; Marsolais C; Annabi B
Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454785
[TBL] [Abstract][Full Text] [Related]
16. The TH1902 Docetaxel Peptide-Drug Conjugate Inhibits Xenografts Growth of Human SORT1-Positive Ovarian and Triple-Negative Breast Cancer Stem-like Cells.
Demeule M; Charfi C; Currie JC; Zgheib A; Danalache BA; Béliveau R; Marsolais C; Annabi B
Pharmaceutics; 2022 Sep; 14(9):. PubMed ID: 36145658
[No Abstract] [Full Text] [Related]
17. Relevant pharmacological interactions between alkylating agents and antiepileptic drugs: Preclinical and clinical data.
Cucchiara F; Ferraro S; Luci G; Bocci G
Pharmacol Res; 2022 Jan; 175():105976. PubMed ID: 34785318
[TBL] [Abstract][Full Text] [Related]
18. Amlodipine Induced Gingival Hyperplasia.
J S; Bennur S; Taneja NS
J Assoc Physicians India; 2021 Oct; 69(10):11-12. PubMed ID: 34781660
[No Abstract] [Full Text] [Related]
19. Spectral imaging of pharmaceutical materials with a compact terahertz difference-frequency generation semiconductor source.
Nakanishi A; Akiyama K; Hayashi S; Satozono H; Fujita K
Anal Methods; 2021 Dec; 13(46):5549-5554. PubMed ID: 34780588
[TBL] [Abstract][Full Text] [Related]
20. Antagonistic, Anti-oxidant, Anti-inflammatory and Anti-diabetic Probiotic Potential of
Khan AN; Yasmin H; Ghazanfar S; Hassan MN; Keyani R; Khan I; Gohar M; Shahzad A; Hashim MJ; Ahmad A
Saudi J Biol Sci; 2021 Nov; 28(11):6069-6076. PubMed ID: 34764740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
